RESMED INC. (RSMDF)
Clinical trial NCT05911646 updates: 1. completion date: 2026-01-31 → 2027-05-31 2. primary completion date: 2026-01-31 → 2026-10-31 3. enrollment: not set → 130 participants
Clinical trial NCT05911646 updates: 1. completion date: 2026-01-31 → 2027-05-31 2. primary completion date: 2026-01-31 → 2026-10-31 3. enrollment: not set → 130 participants
📈 **POSITIVE** • Low confidence analysis (52%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical